To be a leader in the field of molecular diagnosis
Home · About · Brand · Enterprise Style ·
COMPANY INTRODUCTION
Founded in 2016, RocGene (Beijing) Technology Co., Ltd. (hereinafter referred to as RocGene) is a bio-tech company founded by scientists and business elite and driven by core technologies. Rocgene is committed to transforming new technologies in the field of life science research into clinically relevant medical research products, and developing scientific research and molecular diagnostic products with independent intellectual property rights.

RocGene (Xuzhou) Scientific Instrument Co., Ltd. is a wholly-owned subsidiary of RocGene (Beijing) Technology Co., Ltd. It was established in 2019 and has more than 10,000 square meters of various workshops and supporting facilities that meet national GMP standards. The company has three professional production lines: fluorescence quantitative PCR instrument assembly, fluorescence quantitative PCR diagnostic reagent production, and automatic nucleic acid extraction instrument assembly.
10000m2+
Intelligent Manufacturing Center
10000m2+
Operating R&D Center
60+
Patent Certification And Honor
200+
R&D Technicians
300+
Global Partners
COMPANY CULTURE
History
· Founded
2016
2017
· Get 6 soft covering products
· Apply for a patent for invention/utility model "a real-time fluorescence quantitative PCR instrument"
· Obtained "National High-tech Enterprise"
· Obtained the "Zhongguancun High-tech Enterprise"
· Utility model patent: "A real-time fluorescence quantitative PCR instrument" was approved
· Obtained the Nanjing "High-level Entrepreneurial Talent Introduction Program"
· The world's first "time-resolved real-time PCR instrument - Archimed" was released
2018
2019
· Mass production and sales of PCR machines
Established Xuzhou factory
· Participate in the formulation of group standards for food nucleic acid testing for COVID-19
· Help fight the epidemic
· CE certificate - enter overseas markets
· Mini new product launch
2020
2021
· Participated in the formulation of national standards for fluorescence quantitative PCR instruments
· Instrument sales exceeded 2,000 units
·Archimed obtained the Class III medical device certificate
· Beijing headquarters moved to Life Science Park
· The production base was expanded to 10000m2
· Sales of instruments exceeded 10,000 units
2022
HONOR